CARDIOL THERAPEUTICS INC. (CRDL)
Clinical trial NCT02931695 updates: 1. completion date: 2023-10-24 → 2026-02-03 2. primary completion date: 2022-04-24 → 2021-10-19 3. enrollment: 80 → 90 participants 4. study type: INTERVENTIONAL → OBSERVATIONAL 5. collaborators added: Clinical Investigation Center Paris-Est (CIC-2503), AP-HP / INSERM 6. collaborators removed: CIC1901-Centre d'Investigation Clinique Paris-Est, INSERM 1166 ICAN UPMC
📉 **NEGATIVE** • Medium confidence analysis (68%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (21%) **Content type:** Clinical